Skip to content

The study for the suppressive effect on the elevation of postprandial blood glucose level by intake of the food containing seaweed

The study for the suppressive effect on the elevation of postprandial blood glucose level by intake of the food containing seaweed - The study for the suppressive effect on the elevation of postprandial blood glucose level by intake of the food containing seaweed

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000046715
Enrollment
24
Registered
2023-03-15
Start date
2022-01-31
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adult

Interventions

Intake of test food (single ingestion) - washing out (about 1 week) - intake of placebo (single ingestion) Intake of placebo (single ingestion) - washing out (about 1 week) - intake of test food (sing

Sponsors

EP Mediate Co., Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Healthy males and females from 20 to 65 years of age. (2) Fasting blood glucose level is 95 mg / dL or more and less than 126 mg / dL on preliminary examination.

Exclusion criteria

Exclusion criteria: (1) Subjects who are judged as unsuitable for the study based on the results of clinical laboratory test or cardiopulmonary function. (2) Subjects who routinely use medicines and health foods related to blood glucose level and glucose metabolism. (3) Subjects who have possibilities for emerging allergy related to the study. (4) Subjects who have under treatment (including followup). (5) Subjects who have a history of pancreatic disease, endocrine disease (including diseases related to the thyroid gland), liver disease, gastric resection and other diseases that may cause diabetes / glucose metabolism disorders. (6) Subjects who have a disease requiring continuous medication, or serious medical history who needed medication. (7) Subjects whose clinical laboratory tests, blood pressure, and physical measurements on preliminary examination are significantly out of the standard values. (8) Subjects who have a habit of skipping food on a daily basis, or those who have an extremely irregular diet. (9) Subjects who are engaged in day / night shift work, midnight work, or irregular life habits. (10) Subjects who have been diagnosed with insomnia or sleep apnea, or who have extremely irregular sleep habits. (11) Subjects who have a habit of drinking alcohol more than 5 days in a week. (12) Subjects who have a habit of smoking. (13) Subjects who cannot take the meals provided during the study period or those who cannot take the curry and cooked rice in a completely mixed form. (14) Subjects who plan to travel abroad or domestically for more than a week during the study. (15) Subjects who are judged as unsuitable for the study based on the results of lifestyle questionnaire. (16) Subjects who have participated in other clinical study within the last one month prior to the current study or have participated in other clinical studies. (17) Subjects who intend to become pregnant or lactating. (18) Subjects who are judged as unsuitable for the study by the investigator.

Design outcomes

Primary

MeasureTime frame
Area under the curve of blood glucose level (AUC)

Secondary

MeasureTime frame
Postprandial blood glucose levels, Postprandial maximum blood glucose levels, Postprandial blood insulin level, Incremental area under the curve of blood glucose level (iAUC)

Countries

Japan

Contacts

Public ContactSaki Miyayama

EP Mediate Co., Ltd. R&D Support Center Foods Department Trial Planning Section

miyayama.saki392@eps.co.jp070-3023-8210

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026